Showing results (71-80 of 3,274) with videos related to
Sort By:
Pageof 328
Advances in Experimental Medicine and Biology|December 2, 2009
The unexpected link between osteoclasts and the immune systemHiroshi TakayanagiLegal Medicine (Tokyo, Japan)|February 15, 2022
Some tips on age estimation using DNA methylation in saliva samples as an index across the Japanese and Indonesian ethnicitiesHiroko Oka, Maretaningtias Dwi Ariani, Tomohiko Akazaki, et al.Biological & Pharmaceutical Bulletin|July 10, 1998
Thalidomide promotes the release of tumor necrosis factor-alpha (TNF-alpha) and lethality by lipopolysaccharide in miceM Ishikawa, S Kanno, M Takayanagi, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 1, 1996
[Studies on reversing effect of multidrug resistance by dipyridamole. I. modulation of epirubicin-induced effects on cell proliferation and cell cycle by dipyridamole]A Hayashi, S Furusawa, M Takayanagi, et al.Biological & Pharmaceutical Bulletin|April 4, 2000
Exposure to hydrogen peroxide induces cell death via apoptosis in primary cultured mouse hepatocytesS Kanno, M Ishikawa, M Takayanagi, et al.Biological & Pharmaceutical Bulletin|March 8, 2000
Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizoleM Ishikawa, R Fujita, M Takayanagi, et al.Biological & Pharmaceutical Bulletin|April 28, 2000
Potentiation of acetaminophen hepatotoxicity by doxapram in mouse primary cultured hepatocytesS Kanno, M Ishikawsa, M Takayanagi, et al.Methods and Findings in Experimental and Clinical Pharmacology|October 14, 2000
Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquineR Fujita, M Ishikawa, M Takayanagi, et al.International Journal of Immunopharmacology|November 25, 2000
Modification of tumor necrosis factor-induced acute toxicity D-galactosamine challenge by polymyxin B, an anti-endotoxinS Sakaguchi, S Furusawa, K Yokota, et al.Biological & Pharmaceutical Bulletin|October 22, 1998
Potentiation of acetaminophen hepatotoxicity and mortality by doxapram in miceS Kanno, M Ishikawa, M Takayanagi, et al.Pageof 328